Alchemy Becomes First to Certify CO2e Savings in Tech with Greenly Partnership
LONDON–(BUSINESS WIRE)–Supporting businesses on their journey to Net Zero, Alchemy – the fastest-growing circular tech company globally –... Read more.
EVgo Opens First Public Fast Charging Site with Innovative Prefabrication Approach
First in series of charging stations leveraging accelerated deployment approach designed to reduce installation timelines and costs LOS ANGELES–(BUSINESS WIRE)–EVgo... Read more.
Seyfarth Bolsters White-Collar and Investigations Capabilities With Addition of Partner Matthew Banham in London
LONDON–(BUSINESS WIRE)–Seyfarth Shaw LLP announced today the arrival of partner Matthew Banham to the firm’s litigation department, further expanding... Read more.
INFINITI Takes Luxury to New Heights With Dramatic Reveal of All-New 2025 INFINITI QX80
Elevated product reveal showcases flagship SUV on the highest outdoor sky deck in the Western Hemisphere All-new 2025 QX80 makes dramatic debut ahead of 2024 New... Read more.
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Advanced Energy Sales increased 15% year-over-year and 23% quarter-over-quarter in the fourth quarter; increased 18% year-over-year in 2023 CLEARWATER, Fla.–(BUSINESS... Read more.
Exscientia Business and Financial Update for the Full Year 2023
OXFORD, U.K.–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) Recent advancements in the Company’s pipeline, collaborations and operations, as well as... Read more.
AECOM declares quarterly dividend
DALLAS–(BUSINESS WIRE)–AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced that its Board of Directors has declared... Read more.
Kolibri Global Energy Inc. Announces Proved Reserves With Net Present Value of US$483 Million
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Kolibri Global Energy Inc. (the “Company” or “KEI”) (TSX: KEI), is providing the results of its December... Read more.
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase... Read more.
Accenture Reports Second-Quarter Fiscal 2024 Results
New bookings of $21.6 billion, the company’s second-highest ever Generative AI new bookings of over $600 million in the quarter for a total of $1.1 billion... Read more.